Naloxone dosing in the era of synthetic opioids: Applying the Goldilocks principle
Addiction · 2025-11 · 120 (11) · 2165-2172
DOI: 10.1111/add.70060 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Addiction, online erschienen am 08.04.2025. Verfasst von Mariana Gonzalez Utrilla und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. Hauptthemen laut MEDLINE: Naloxone, Narcotic Antagonists, Analgesics, Opioid, Opiate Overdose. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The opioid overdose epidemic remains a critical public health crisis. In recent years, synthetic opioids like fentanyl and nitazenes, have driven a sharp rise in deaths. Naloxone, an opioid receptor antagonist, has been established as a key intervention for reversing opioid overdoses and saving lives. However, there remains a critical need to optimize naloxone dosing strategies. This article examines the challenges of both under‐dosing and over‐antagonism in naloxone administration, emphasizing the importance of a tailored approach to overdose management. A ‘just the right dose’ approach is essential for minimizing the risks of over‐antagonism while still reversing opioid overdose. This involves starting with a modest naloxone dose and carefully titrating it based on the patient's response, considering factors such as opioid type, overdose severity, and opioid tolerance. A tailored approach to naloxone dosing may present challenges for non‐medically trained responders but it can ensure that as many people as possible receive the right dose of naloxone when they need it. Training programs should also emphasize the importance of first aid and supportive care, including airway management and alerting emergency services, as well as careful monitoring of the patient's response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
- South London and Maudsley NHS Foundation Trust, London, UK.
- Centre for Social Research in Health, University of New South Wales Sydney, New South Wales, Australia.
- Division of Prehospital Services, Oslo University Hospital, Oslo, Norway.
- Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway.
- Disease Elimination Program, Burnet Institute, Melbourne, Australia.
ORCID-Profile: Mariana Gonzalez Utrilla, Edward Chesney, Joanne Neale, Nicola Metrebian, Nicola Kalk, Arne Kristian Skulberg, John Strang
Zitieren
APA
Gonzalez Utrilla, M., Chesney, E., Neale, J., Metrebian, N., Kalk, N., Skulberg, A. K., Dietze, P., Smith, M., & Strang, J. (2025). Naloxone dosing in the era of synthetic opioids: Applying the Goldilocks principle. Addiction, 120(11), 2165-2172. https://doi.org/10.1111/add.70060
Vancouver
Gonzalez Utrilla M, Chesney E, Neale J, Metrebian N, Kalk N, Skulberg AK, et al. Naloxone dosing in the era of synthetic opioids: Applying the Goldilocks principle. Addiction. 2025;120(11):2165-2172. doi:10.1111/add.70060
BibTeX
@article{GonzalezUtrilla2025,
author = {Gonzalez Utrilla, Mariana and Chesney, Edward and Neale, Joanne and Metrebian, Nicola and Kalk, Nicola and Skulberg, Arne Kristian and Dietze, Paul and Smith, Martin and Strang, John},
title = {Naloxone dosing in the era of synthetic opioids: Applying the Goldilocks principle},
journal = {Addiction},
year = {2025},
volume = {120},
number = {11},
pages = {2165--2172},
doi = {10.1111/add.70060}
}
EUVIMED